𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Glutathione S-transferases T1 null genotype is associated with susceptibility to aristolochic acid nephropathy

✍ Scribed by Bicheng Chen; Yongheng Bai; Mei Sun; Xiaojie Ni; Yunxiu Yang; Yirong Yang; Shaoling Zheng; Feifei Xu; Shengchuan Dai

Publisher
Springer Netherlands
Year
2011
Tongue
English
Weight
186 KB
Volume
44
Category
Article
ISSN
0301-1623

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Glutathione S-transferase T1 null-genoty
Glutathione S-transferase T1 null-genotype is associated with an increased risk of lung cancer
✍ Mette Sørensen; Herman Autrup; Anne Tjønneland; Kim Overvad; Ole Raaschou-Nielse 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 85 KB 👁 2 views

## Abstract Glutathione S‐transferases (GSTs) are involved in detoxification of carcinogens, __e.g__., from tobacco smoke. Therefore, polymorphisms in the GST genes have been considered as potential modifiers of individual cancer risk. In a population‐based case‐cohort study where cases and the sub

Glutathione S-transferase M1 and T1 null
Glutathione S-transferase M1 and T1 null genotypes increase susceptibility to drug-induced liver injury
✍ Virginia Leiro Fernández; Alberto Fernández-Villar; Rafael Vázquez Gallardo; Dia 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB 👁 1 views

We appreciate the comments of Leiro et al. on the role of the combined glutathione-S-transferase M1 (GSTM1) and glutathione-S-transferase T1 (GSTT1) null genotypes in determining the susceptibility to developing idiosyncratic drug-induced liver injury (DILI) as a general mechanism that occurs regard

Glutathione S-transferase m1 and t1 null
Glutathione S-transferase m1 and t1 null genotypes increase susceptibility to idiosyncratic drug-induced liver injury
✍ M. Isabel Lucena; Raúl J. Andrade; Carmen Martínez; Eugenia Ulzurrun; Elena Garc 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 137 KB 👁 1 views

on behalf of the Spanish Group for the Study of Drug-Induced Liver Disease Individual vulnerability to drug-induced liver injury (DILI) might result from deficiencies in the detoxification process, which determines the level of exposure to the reactive metabolite. We evaluated whether a genetically